Article History
Received: 3 February 2021
Accepted: 3 April 2021
First Online: 8 June 2021
Declarations
:
: PB has previously approached both Sanofi to trial Caplacizumab and Lees pharma to trial Anfibatide in COVID + ve patients. GC, GP, and OJ none relevant.
: Ethical approval was not required for this letter.
: Consent to participate was not required.
: Consent for publication is not required.
Free to read: This content has been made available to all.